PE20080844A1 - Uso de moduladores lxr para la prevencion y tratamiento del envejecimiento de la piel - Google Patents
Uso de moduladores lxr para la prevencion y tratamiento del envejecimiento de la pielInfo
- Publication number
- PE20080844A1 PE20080844A1 PE2007001262A PE2007001262A PE20080844A1 PE 20080844 A1 PE20080844 A1 PE 20080844A1 PE 2007001262 A PE2007001262 A PE 2007001262A PE 2007001262 A PE2007001262 A PE 2007001262A PE 20080844 A1 PE20080844 A1 PE 20080844A1
- Authority
- PE
- Peru
- Prior art keywords
- lxr
- prevention
- treatment
- skin aging
- oxisterol
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title 1
- 230000009759 skin aging Effects 0.000 title 1
- 102000004311 liver X receptors Human genes 0.000 abstract 4
- 108090000865 liver X receptors Proteins 0.000 abstract 4
- RZPAXNJLEKLXNO-UHFFFAOYSA-N (20R,22R)-3beta,22-Dihydroxylcholest-5-en Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C(O)CCC(C)C)C1(C)CC2 RZPAXNJLEKLXNO-UHFFFAOYSA-N 0.000 abstract 1
- RZPAXNJLEKLXNO-GFKLAVDKSA-N (22R)-22-hydroxycholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)[C@H](O)CCC(C)C)[C@@]1(C)CC2 RZPAXNJLEKLXNO-GFKLAVDKSA-N 0.000 abstract 1
- 102100024005 Acid ceramidase Human genes 0.000 abstract 1
- 101000975753 Homo sapiens Acid ceramidase Proteins 0.000 abstract 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 abstract 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 abstract 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SGIWFELWJPNFDH-UHFFFAOYSA-N n-(2,2,2-trifluoroethyl)-n-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide Chemical compound C1=CC(C(O)(C(F)(F)F)C(F)(F)F)=CC=C1N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1 SGIWFELWJPNFDH-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229930002330 retinoic acid Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN MODULADOR LXR SELECCIONADO DE OXISTEROL, NO-OXISTEROL (NATURAL O SINTETICO), 22(R)HIDROXICOLESTEROL, N-(2,2,2-TRIFLUOROETIL)-N-{4-[2,2,2-TRIFLUORO-1-HIDROXI-1-(TRIFLUOROMETIL)ETIL]FENIL}BENCENO SULFONAMIDA, ENTRE OTROS. OPCIONALMENTE PUEDE CONTENER O NO UN LIGANDO, COMO, ACIDO ALL-TRANS RETINOICO, ACIDO 6-[3-(1-ADAMANTIL)-4-METOXIFENIL]-2-NAFTOICO, ENTRE OTROS; UN ANTIOXIDANTE; FILTRO SOLAR; RETINOIDES, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION. EL MODULADOR DE LXR, INDUCE A LA EXPRESION DE LXR , LXRß, TIMP1, ASAH1, ENTRE OTROS, POR LO QUE DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO ANTI-ENVEJECIMIENTO DE LA PIEL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84568506P | 2006-09-19 | 2006-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080844A1 true PE20080844A1 (es) | 2008-08-15 |
Family
ID=39110878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007001262A PE20080844A1 (es) | 2006-09-19 | 2007-09-19 | Uso de moduladores lxr para la prevencion y tratamiento del envejecimiento de la piel |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080070883A1 (es) |
AR (1) | AR062911A1 (es) |
PE (1) | PE20080844A1 (es) |
TW (1) | TW200819145A (es) |
WO (1) | WO2008036238A2 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9532994B2 (en) | 2003-08-29 | 2017-01-03 | The Regents Of The University Of California | Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins |
WO2007098281A2 (en) * | 2006-02-27 | 2007-08-30 | Regents Of The University Of California | Oxysterol compounds and the hedgehog pathway |
WO2008011071A2 (en) * | 2006-07-19 | 2008-01-24 | The Regents Of The University Of California | Interactions of hedgehog and liver x receptor signaling pathways |
AU2007339325A1 (en) * | 2006-12-19 | 2008-07-10 | The Regents Of The University Of California | Inhibition of PPAR gamma expression by specific osteogenic oxysterols |
EP2146724A2 (en) * | 2007-03-16 | 2010-01-27 | The Regent of the University of California | Role of hedgehog signaling in atherosclerosis and cardiovascular disease |
CN101679311A (zh) * | 2007-05-18 | 2010-03-24 | 惠氏公司 | 喹唑啉化合物 |
CA2698928A1 (en) * | 2007-09-28 | 2009-04-09 | Absolute Science, Inc. | Compounds and methods for treating zinc matrix metalloprotease dependent diseases |
US9526737B2 (en) * | 2007-12-03 | 2016-12-27 | The Regents Of The University Of California | Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling |
CN101945871A (zh) * | 2007-12-21 | 2011-01-12 | 惠氏有限责任公司 | 咪唑并[1,2-a]吡啶化合物 |
WO2009086130A1 (en) * | 2007-12-21 | 2009-07-09 | Wyeth | Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
CA2710461A1 (en) * | 2007-12-21 | 2009-07-09 | Wyeth Llc | Benzimidazole compounds |
JP2011507901A (ja) * | 2007-12-21 | 2011-03-10 | ワイス・エルエルシー | ピラゾロ[1,5−a]ピリミジン化合物 |
JP2011520451A (ja) | 2008-05-14 | 2011-07-21 | ダームテック インターナショナル | 核酸解析による黒色腫および日光黒子の診断法 |
WO2010033360A1 (en) * | 2008-09-19 | 2010-03-25 | 1/3 Absolute Science, Inc. | Methods of treating a botulinum toxin related condition in a subject |
WO2010062762A2 (en) * | 2008-11-03 | 2010-06-03 | Dermachip Inc. | Compositions and methods for reducing the signs of aging of the skin |
JP2012508250A (ja) * | 2008-11-07 | 2012-04-05 | ワイス・エルエルシー | キノキサリン系のlxrモジュレーター |
WO2010059627A1 (en) * | 2008-11-19 | 2010-05-27 | Wyeth Llc | Polar quinazolines as liver x receptors ( lxrs ) modulators |
WO2011006087A1 (en) * | 2009-07-10 | 2011-01-13 | The Regents Of The University Of California | Inhibition of ppar gamma expression in preadipocyte cells by oxysterols |
KR101766393B1 (ko) * | 2010-11-30 | 2017-08-10 | (주)아모레퍼시픽 | 블레오마이신 하이드로라제를 이용한 건조 피부 개선물질 스크리닝 방법 |
US20140080920A1 (en) * | 2011-05-17 | 2014-03-20 | Chanel Parfums Beaute | Large, hs6st2 or st8sia1 activators for preventing and/or attenuating skin ageing and/or hydrating skin |
AU2012348700B2 (en) | 2011-12-06 | 2015-08-27 | Unilever Plc | Skin anti-ageing composition |
JP6262723B2 (ja) | 2012-05-07 | 2018-01-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | オキシステロールアナログoxy133は、骨発生及びヘッジホッグシグナル伝達を誘導し、脂肪生成を阻害する |
AU2014259672A1 (en) | 2013-05-02 | 2015-12-03 | The Regents Of The University Of California | Bone-selective osteogenic oxysterol-bone targeting agents |
CN105132358B (zh) * | 2015-07-29 | 2019-12-06 | 苏州诺普再生医学有限公司 | 培养获得组织工程表皮的方法及其应用 |
EP3397258A2 (en) * | 2015-12-30 | 2018-11-07 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (CONICET) | Use of brassinosteroid analogs for the treatment of dermal disorders by selectively modulating liver x receptors (lxr) and dermal disease treatment by brassinosteroid analogs acting as selective liver x receptor (lxr) modulators |
US11976332B2 (en) | 2018-02-14 | 2024-05-07 | Dermtech, Inc. | Gene classifiers and uses thereof in non-melanoma skin cancers |
EP3948290A4 (en) | 2019-03-26 | 2023-08-09 | Dermtech, Inc. | NEW GENE CLASSIFIERS AND THEIR USES FOR SKIN CANCERS |
JP2022529409A (ja) * | 2019-04-05 | 2022-06-22 | ダームテック,インク. | Uv損傷のモニタリングに使用するための新規な遺伝子分類子 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60120805A (ja) * | 1983-11-30 | 1985-06-28 | Akira Kitano | 皮膚化粧料 |
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
US6060515A (en) * | 1997-01-24 | 2000-05-09 | The Regents Of The University Of California | Treatment of skin conditions by use of PPARα activators |
US6316503B1 (en) * | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
US20030086923A1 (en) * | 1999-12-13 | 2003-05-08 | Sparrow Carl P. | Method for the prevention and/or treatment of atherosclerosis |
US20020010128A1 (en) * | 2000-04-13 | 2002-01-24 | Parks Thomas P. | Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism |
JP2005509610A (ja) * | 2001-10-04 | 2005-04-14 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 皮膚の表皮障壁発達の増進 |
EP1463726A2 (en) * | 2001-12-21 | 2004-10-06 | Pharmacia Corporation | Aromatic thioether liver x-receptor modulators |
JP5082033B2 (ja) * | 2001-12-21 | 2012-11-28 | エグゼリクシス パテント カンパニー エルエルシー | Lxrのモジュレーター |
US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
AU2003217276A1 (en) * | 2002-02-28 | 2003-09-16 | Eli Lilly And Company | Method of treating atherosclerosis and hypercholesterolemia |
AU2003241601A1 (en) * | 2002-05-24 | 2003-12-12 | Pharmacia Corporation | Anilino liver x-receptor modulators |
JP3694494B2 (ja) * | 2002-07-02 | 2005-09-14 | 三井金属鉱業株式会社 | 車両スライド扉の動力装置 |
BR0314390A (pt) * | 2002-09-17 | 2005-07-19 | Pharmacia Corp | Moduladores aromáticos dos receptores hepáticos x |
WO2004058175A2 (en) * | 2002-12-23 | 2004-07-15 | Irm Llc | Novel use of liver x receptor agonists |
US20040259948A1 (en) * | 2003-01-10 | 2004-12-23 | Peter Tontonoz | Reciprocal regulation of inflammation and lipid metabolism by liver X receptors |
WO2004064769A2 (en) * | 2003-01-21 | 2004-08-05 | Hector Herrera | Methods for making and using topical delivery agents |
CN1805948A (zh) * | 2003-04-21 | 2006-07-19 | 塔格拉生物科技有限公司 | 抗坏血酸的稳定衍生物 |
US20050009837A1 (en) * | 2003-05-20 | 2005-01-13 | City Of Hope | Modulators of lipid metabolism and methods of use |
KR20070001922A (ko) * | 2003-12-12 | 2007-01-04 | 와이어쓰 | 심장혈관질환 치료에 유용한 퀴놀린 |
TW200605886A (en) * | 2004-08-03 | 2006-02-16 | Wyeth Corp | Indazoles useful in treating cardiovascular diseases |
JP4644714B2 (ja) * | 2004-12-22 | 2011-03-02 | エフ.ホフマン−ラ ロシュ アーゲー | 新規なシクロヘキサン誘導体 |
CN101166730A (zh) * | 2005-03-01 | 2008-04-23 | 惠氏公司 | 噌啉化合物及其作为肝x受体调节剂的用途 |
-
2007
- 2007-09-18 US US11/901,514 patent/US20080070883A1/en not_active Abandoned
- 2007-09-18 WO PCT/US2007/020148 patent/WO2008036238A2/en active Application Filing
- 2007-09-19 PE PE2007001262A patent/PE20080844A1/es not_active Application Discontinuation
- 2007-09-19 AR ARP070104148A patent/AR062911A1/es unknown
- 2007-09-19 TW TW096134868A patent/TW200819145A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AR062911A1 (es) | 2008-12-17 |
WO2008036238A3 (en) | 2011-08-11 |
WO2008036238A2 (en) | 2008-03-27 |
US20080070883A1 (en) | 2008-03-20 |
TW200819145A (en) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20080844A1 (es) | Uso de moduladores lxr para la prevencion y tratamiento del envejecimiento de la piel | |
ES2602986T3 (es) | Nuevas composiciones cosméticas y/o farmacológicas y sus aplicaciones | |
CR11648A (es) | Composicion que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes acidas | |
DE602005024590D1 (de) | Phenothiazin-Derivat zur Wundheilung | |
CO6430467A2 (es) | Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas | |
NO20083780L (no) | Topisk sammensetning omfattende en antibakteriell substans | |
AR054805A1 (es) | Composiciones topicas para el tratamiento de la piel | |
AR032287A1 (es) | Una composicion cosmetica para el cuidado de la piel y metodos cosmeticos que utilizan dicha composicion | |
CL2009001484A1 (es) | Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia. | |
CL2007001873A1 (es) | Acido((3s))-6-((¨2,6-dimetil-4-(3-(metilsulfonil)-propoxi)bifenil-3-il)metoxi-2,3-dihidro-1-benzofuran-3-il)acetico o una sal del mismo | |
BRPI0509372A (pt) | composição, produto de clareamento da pele, métodos de inibir a produção de melanina, de aumentar a relação de melanina clara para a melanina escura na pele de um mamìfero, e de inibir, na pele de um indivìduo, o transporte da melanina dos melanócitos para os queratinócitos, e, uso de uma composição | |
BR0317275A (pt) | Liberação controlada de uma substância ativa em um ambiente de gordura alta | |
CL2007001915A1 (es) | Compuesto cristalino de 6-[4-cloro-3-(4-etoxibencil)fenil]tetrahidropiran-2,3,4,5,-tetraol; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y su uso para preparar un medicamento para tratar diabetes, dislipidemia, obesidad, entre otras. | |
CL2008000897A1 (es) | Sal de arginina y uno o mas ácidos conjugados; composición de cuidado oral que comprende dicha sal; uso para reducir o inhibir la formacion de caries, desmineralizacion de los dientes; reducir la hipersensibilidad de los dientes, reducir o inhibir la gingivitos entre otras. | |
BRPI1106572B8 (pt) | Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso | |
BRPI0811956A8 (pt) | Solução tópica não aquosa de diclofenaco e processo para sua preparação | |
BR112014002769A2 (pt) | método e kit depilatório | |
ES2564172T3 (es) | Utilización de una composición cosmética para el cuidado de las pieles grasas | |
CL2008001194A1 (es) | Composicion farmaceutica que comprende florfenico, una ciclodextrina y agua, un solvente y7o una mezcka de los mismos, con al menos 5% de solvente; kit que la contiene; complejo de florfenicol, util para tratr enfermedades respiratorias en animales | |
CL2007001759A1 (es) | Compuesto metformina r-(+) lipoato; mezcla que comprende metformina y acido r-(+) lipoico; composicion farmaceutica que comprende el compuesto; metodo para preparar el compuesto; kit; y uso para tratar la diabetes. | |
AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
ECSP056071A (es) | Nueva difenilazetidinona con características fisiológicas mejoradas, correspondiente método de producción, medicamentos que contienen dicho compuesto y su uso | |
CL2008000613A1 (es) | Uso del acido (s,s)-(1-aminometil-3,4-dimetil-ciclopentil)-acetico para preparar un medicamento util para tratar tinnitis en un mamifero. | |
RU2009101326A (ru) | Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту | |
UY31788A (es) | Formulación farmacéutica sólida con liberación retardada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |